Biotechnology Sector

A new study published in Energy, Sustainability and Society reveals that geopolitical risks originating from the Russian Federation and the Middle East significantly exacerbate both energy and carbon inequalities across European nations.

A case-control study found that monocyte-to-HDL and lymphocyte-to-monocyte ratios significantly differed in women with fibromyalgia and independently tracked distinct symptoms.

A knock-in mouse study reveals that the cetacean Tbx4-HLEA enhancer delays early embryonic hindlimb bud outgrowth before functional enhancer redundancy rescues limb development.

A cross-sectional study in Lebanon found that 54.29% of hospital pharmacies and 17.55% of community pharmacies practice extemporaneous compounding.

A cross-sectional study of adults with HIV in Uganda identified significant sex differences in cardiovascular risk factors, with men exhibiting higher substance use and Framingham risk scores while women showed higher rates of obesity and dyslipidemia.

A retrospective study of 4,448 men links ambient PM2.5 and PM10 exposure to reductions in sperm concentration and total sperm count.

A systematic review of 160 observational studies shows that reported COVID-19 vaccine adverse event rates vary by nearly two orders of magnitude depending on denominator structure, surveillance methods, and study quality.

A two-database study reveals that evaluating both serum creatinine and urine output identifies critically ill patients with cirrhosis at higher risk of short-term kidney disease progression.

A cross-sectional study finds that measurement variability and associations with body mass index and parity limit anogenital distance as a gynecological biomarker.

A six-week foot core training program developed through a knowledge transfer scheme was associated with improved jump performance, sprint times, dynamic balance, and arch stability in male amateur football players.

A systematic review and meta-analysis of 12 randomized controlled trials found that Tai Chi exercise may improve shoulder mobility, overall shoulder function, and physical fatigue in breast cancer survivors, though high heterogeneity and unreported adverse events limit certainty.

Mississippi State University doctoral researcher Sam Mathes earned national recognition for using near-infrared spectroscopy to non-invasively assess the health of Eastern hellbenders.

A multicenter study of 85 patients reveals modular non-fusion knee arthrodesis yields moderate implant survival, substantial amputation risks in aseptic cases, and poor functional outcomes.

An analysis of employment records from Tongji University reveals that urban and rural planning graduates diversified their career choices and pursued individualized pathways between 2014 and 2023.

A retrospective study of 91 eyes found that entering measured posterior corneal astigmatism into the Barrett toric calculator altered lens planning recommendations in 29.7 percent of cases, predominantly by reducing the proposed cylinder power step.

Surveys of pomegranate orchards in southern Iran revealed that emerging Fusarium iranicum and Fusarium clavum isolates drive canker disease, exhibiting significant variation in pathogen aggressiveness and cultivar-dependent host susceptibility.

A benchmark across 6,900 outputs revealed that reasoning modes substantially increased clinical text extraction accuracy while noticeably lengthening inference latency.

A retrospective study at ALERT Comprehensive Specialized Hospital in Addis Ababa found that diabetes was linked to higher crude COVID-19 in-hospital mortality and worse laboratory markers, but was not independently associated with death after multivariable adjustment.

A review in Agricultural Products Processing and Storage details how stable isotope techniques clarify the mechanisms by which organic fertilizers reduce nitrate accumulation in various vegetable types compared to conventional chemical fertilizers.

An exploratory cross-sectional study demonstrates that an interactive 3D-printed physical simulator feasibly differentiates neurosurgeons and trainees across experience levels during simulated endoscopic discectomy portal placement.

Preclinical Pulse in November 2026 features research across therapeutic technologies, including small molecule and gene therapy approaches. The post Preclinical Pulse: The research catching our eye in November 2026  appeared first on Labiotech.eu. © Labiotech UG and Labiotech.eu. Unauthorized use and/or duplication of this material without express and written permission from this site’s author and/or owner is strictly prohibited. Excerpts and links may be used, provided that full and clear credit is given to Labiotech UG and Labiotech.eu with appropriate and specific direction to the original content.

Switzerland is a booming biotech hotspot in Europe boasting many high-profile companies. Here are 10 promising Swiss biotech companies. The post Biotech in Switzerland: 10 companies to watch in 2027  appeared first on Labiotech.eu. © Labiotech UG and Labiotech.eu. Unauthorized use and/or duplication of this material without express and written permission from this site’s author and/or owner is strictly prohibited. Excerpts and links may be used, provided that full and clear credit is given to Labiotech UG and Labiotech.eu with appropriate and specific direction to the original content.

The name change from PCOS to PMOS hopes to reverse misdiagnoses rates and spread awareness about a complex endocrine disorder. The post Zooming out from ovaries: how has renaming PMOS changed lives?  appeared first on Labiotech.eu. © Labiotech UG and Labiotech.eu. Unauthorized use and/or duplication of this material without express and written permission from this site’s author and/or owner is strictly prohibited. Excerpts and links may be used, provided that full and clear credit is given to Labiotech UG and Labiotech.eu with appropriate and specific direction to the original content.

Joining us is Shashi Koduru, Senior Director of Business Development at Vector BioMed. We discuss how he finds the right partners, and makes short meetings productive. The post How to turn a BIO-Europe meeting into a lasting partnership appeared first on Labiotech.eu. © Labiotech UG and Labiotech.eu. Unauthorized use and/or duplication of this material without express and written permission from this site’s author and/or owner is strictly prohibited. Excerpts and links may be used, provided that full and clear credit is given to Labiotech UG and Labiotech.eu with appropriate and specific direction to the original content.

We look at some of the key biotech developments, companies, and clinical data to watch at AHA Scientific Sessions 2026. The post From gene editing to RNA therapies: The biotech trends to look out for at AHA Scientific Sessions 2026 appeared first on Labiotech.eu. © Labiotech UG and Labiotech.eu. Unauthorized use and/or duplication of this material without express and written permission from this site’s author and/or owner is strictly prohibited. Excerpts and links may be used, provided that full and clear credit is given to Labiotech UG and Labiotech.eu with appropriate and specific direction to the original content.

The companies Summit Therapeutics, Dren Bio, and Lycia Therapeutics bagged the biggest biotech funding rounds overall in October 2026. The post The biggest biotech funding rounds in October 2026 appeared first on Labiotech.eu. © Labiotech UG and Labiotech.eu. Unauthorized use and/or duplication of this material without express and written permission from this site’s author and/or owner is strictly prohibited. Excerpts and links may be used, provided that full and clear credit is given to Labiotech UG and Labiotech.eu with appropriate and specific direction to the original content.

The most expensive biotech M&A in October 2026 was worth $2 billion. Licensing deals spanned across therapeutic technologies. The post Top biotech deals in October 2026  appeared first on Labiotech.eu. © Labiotech UG and Labiotech.eu. Unauthorized use and/or duplication of this material without express and written permission from this site’s author and/or owner is strictly prohibited. Excerpts and links may be used, provided that full and clear credit is given to Labiotech UG and Labiotech.eu with appropriate and specific direction to the original content.

Explore how integrated infrastructure can help advanced therapy supply chains reduce fragmentation, maintain continuity, and support global growth. The post Why global expansion is changing the shape of the ATMP supply chain appeared first on Labiotech.eu. © Labiotech UG and Labiotech.eu. Unauthorized use and/or duplication of this material without express and written permission from this site’s author and/or owner is strictly prohibited. Excerpts and links may be used, provided that full and clear credit is given to Labiotech UG and Labiotech.eu with appropriate and specific direction to the original content.

While Teva is initially known for its generics business, the company is shifting its strategy to build a more innovative pipeline. The post Teva’s pipeline in 2027: Can it sustain its transformation?  appeared first on Labiotech.eu. © Labiotech UG and Labiotech.eu. Unauthorized use and/or duplication of this material without express and written permission from this site’s author and/or owner is strictly prohibited. Excerpts and links may be used, provided that full and clear credit is given to Labiotech UG and Labiotech.eu with appropriate and specific direction to the original content.

ESMO 2026 was the hotspot for cancer research readouts, with encouraging trials across indications and therapeutic candidates. The post ESMO 2026: readouts and highlights at the oncology summit  appeared first on Labiotech.eu. © Labiotech UG and Labiotech.eu. Unauthorized use and/or duplication of this material without express and written permission from this site’s author and/or owner is strictly prohibited. Excerpts and links may be used, provided that full and clear credit is given to Labiotech UG and Labiotech.eu with appropriate and specific direction to the original content.

In part three of our series, I spoke with Ryan Confer, President and CEO of Genprex, about the company’s move from cancer into diabetes. The post Genprex bets on a one-time gene therapy for diabetes (Part 3 of 3) appeared first on Labiotech.eu. © Labiotech UG and Labiotech.eu. Unauthorized use and/or duplication of this material without express and written permission from this site’s author and/or owner is strictly prohibited. Excerpts and links may be used, provided that full and clear credit is given to Labiotech UG and Labiotech.eu with appropriate and specific direction to the original content.

There is a lot of research going on in the therapeutic field of idiopathic pulmonary fibrosis, in the hope that more treatments reach patients sooner. The post New idiopathic pulmonary fibrosis drugs on the way  appeared first on Labiotech.eu. © Labiotech UG and Labiotech.eu. Unauthorized use and/or duplication of this material without express and written permission from this site’s author and/or owner is strictly prohibited. Excerpts and links may be used, provided that full and clear credit is given to Labiotech UG and Labiotech.eu with appropriate and specific direction to the original content.

With significant growth in activities globally, our /local page has strained to keep up and simply is not a great...